Skip to main content
Log in

High Prevalence of Steatorrhea in 101 Diabetic Patients Likely to Suffer from Exocrine Pancreatic Insufficiency According to Low Fecal Elastase 1 Concentrations: A Prospective Multicenter Study

  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Impaired exocrine pancreatic secretion has been frequently observed in diabetic patients by different methods, including direct function tests. However, the clinical importance remained unclear. In the present study, the fecal fat excretion in patients with type 1 or type 2 diabetes mellitus and exocrine dysfunction according to fecal elastase 1 concentrations <100 μg/g was investigated. Subjects with a history of gastrointestinal cancer, gastrointestinal surgery, alcohol abuse, or inflammatory diseases were excluded. In 101 patients the mean (±SD) fat excretion was 9.19 ± 5.39 g. Only 41 patients (40.6%) had normal fat excretion <7 g/day. In 40 patients (39.6%), it was higher than 10 g/day, indicating relevant steatorrhea. The fat excretion did not correlate with diabetes type, duration, or clinical symptoms. This finding is of some clinical importance and might influence pathophysiological concepts and the management of diabetic patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

REFERENCES

  1. Chey WY, Shay H, Shuman CR: External pancreatic secretion in diabetes mellitus. Ann Intern Med 59:812–821, 1963

    Google Scholar 

  2. Vacca JB, Henke WJ, Knight WA: The exocrine pancreas in diabetes mellitus. Ann Intern Med 61:242–247, 1964

    Google Scholar 

  3. Frier BM, Saunders JHB, Wormsley KG, Bouchier IAD: Exocrine pancreatic function in juvenile-onset diabetes mellitus. Gut 17:685–691, 1976

    Google Scholar 

  4. Lankisch PG, Manthey G, Otto J, Talaulicar M, Willms B, Creutzfeldt W: Exocrine pancreatic function in insulin-dependent diabetes mellitus. Digestion 25:210–216, 1982

    Google Scholar 

  5. Gilbeau J, Poncelet V, Libon E, Derue G, Heller FR: The density, contour and thickness of the pancreas in diabetics. Am J Roentgenol 159:527–531, 1992

    Google Scholar 

  6. Lazarus SS, Volk BW: Pancreas in maturity-onset diabetes. Arch Pathol (Chicago) 71:44–48, 1961

    Google Scholar 

  7. Gepts W: Pathology of the pancreas in juvenile diabetes. Diabetes 14:619–633, 1965

    Google Scholar 

  8. Lohr M, Kloppel G: Residual insulin positivity and pancreatic atrophy in relation to duration of chronic type 1 (insulin dependent) diabetes mellitus and microangiopathy. Diabetologia 30:757–762, 1987

    Google Scholar 

  9. Kobayashi T, Nakanishi K, Sugimoto T, Murase T, Kosaka K: Histopathological changes of the pancreas in islet cell antibodies (ICA)-positive subjects before and after the clinical onset of insulin-dependent diabetes mellitus. Diabetes 37:24A, 1988

    Google Scholar 

  10. Nakanishi K, Kobayashi T, Miyashita H, Okubo M, Sugimoto T, Murase T, Hashimoto M, Fukuchi M, Kosaka K: Exocrine pancreatic ductograms in insulin-dependent diabetes mellitus. Am J Gastroenterol 89:762–766, 1994

    Google Scholar 

  11. Hardt PD, Killinger A, Nalop J, Schnell-Kretschmer H, Zekorn T, Klör HU: Chronic pancreatitis and diabetes mellitus. A retrospective analysis of 156 ERCP investigations in patients with insulin-dependent and non-insulin-dependent diabetes mellitus. Pancreatology 2:30–32, 2002

    Google Scholar 

  12. Nakamura Z, Imamura K, Takebe K, Terada A, Arai Y, Tandoh Y, Yamada N, Ishii M, Machida K, Suda T: Correlation between pancreatic endocrine and exocrine function and characteristics of pancreatic endocrine function in patients with diabetes mellitus owing to chronic pancreatitis. Int J Pancreatol 20:169–175, 1996

    Google Scholar 

  13. Warren KW, Fallis LS, Barron J: Acute Pancreatitis and diabetes. Ann Surg 132:1003–1010, 1950

    Google Scholar 

  14. Larsen S: Diabetes secondary to chronic pancreatitis. Dan Med Bull 40:153–162, 1993

    Google Scholar 

  15. Alberti KGMM: Diabetes secondary to pancreatopathy: an example of brittle diabetes. In Diabetes Secondary to Pancreatopathy. A Tiengo, KGMM Alberti, S DelPrato, M Vranic (eds). Amsterdam, Excerpta Medica, 1988, pp 7–20

    Google Scholar 

  16. Williams JA, Goldfine ID: The insulin-pancreatic acinar axis. Diabetes 34:980–986, 1985

    Google Scholar 

  17. Henderson JR: Why are the islets of Langerhans? Lancet 2:469–470, 1969

    Google Scholar 

  18. El Ne Wihi H, Dooley CP, Saad C: Impaired exocrine pancreatic function in diabetics with diarrhoea and peripheral neuropathy. Dig Dis Sci 33:705–710, 1988

    Google Scholar 

  19. Dyck WP, Rudick J, Hoexter B, Janowitz HD: Influence of glucagon on pancreatic exocrine secretion. Gastroenterology 56:531–537, 1969

    Google Scholar 

  20. Unger RH, Aguilar-Parada E, Müller WA, Eisentraut AM: Studies of pancreatic alpha cell function in normal and diabetic subjects. J Clin Invest 49:837–848, 1970

    Google Scholar 

  21. Korc M: Islet growth factors: Curing diabetes and preventing chronic pancreatitis? J Clin Invest 92:1113–1114, 1993

    Google Scholar 

  22. Lazarus SS, Volk BW: The effect of protracted glucagon administration on blood glucose and on pancreatic morphology. Endocrinology 63:359–371, 1958

    Google Scholar 

  23. Kobayashi T, Nakanishi K, Kajio H, Morinaga S, Sugimoto T, Murase T, Kosaka K: Pancreatic cytokeratin: an antigen of pancreatic exocrine cell autoantibodies in type 1 (insulin-dependent) diabetes mellitus. Diabetologia 33:363–370, 1990

    Google Scholar 

  24. Mally IM, Cirulli V, Hayek A, Otonkosky T: ICA 69 is expressed equally in the human endocrine and exocrine pancreas. Diabetologia 39:474–480, 1996

    Google Scholar 

  25. Sanvito F, Nicols A, Herrera P-J, Huarte J, Wohlwend A, Vassali J-D, Orci L: TGF-ß1 overexpression in murine pancreas induces chronic pancreatitis and, together with TNF-α, triggers insulin-dependent diabetes. Biochem Biophys Res Commun 217:1279–1286, 1995

    Google Scholar 

  26. Hardt PD, Krauss A, Bretz L, Porsch-Oezcueruemez M, Schnell-Kretschmer H, Mäser E, Bretzel RG, Zekorn T, Kloer HU: Pancreatic exocrine function in patients with type-1 and type-2 diabetes mellitus. Acta Diabetol 37:105–110, 2000

    Google Scholar 

  27. Rathmann W, Haastert B, Icks A, Giani G, Hennings S, Mitchell J, Curren S, Wareham NJ: Low fecal elastase 1 concentrations in type 2 diabetes. Scand J Gastroenterol 36:1056–1061, 2001

    Google Scholar 

  28. Icks A, Haastert B, Giani G, Rathmann W: Low fecal elastase 1 in type 1 diabetes mellitus. Z Gastroenterol 39:823–830, 2001

    Google Scholar 

  29. Van de Kamer JH, ten Bockel H, Weijers HA: Rapid method for the determination of fat in feces. J Biol Chem 177:347–355, 1949

    Google Scholar 

  30. Löser C, Möllgaard A, Fölsch UR: Faecal elastase 1: a novel, highly sensitive, and specific tubeless pancreatic function test. Gut 39:580–586, 1996

    Google Scholar 

  31. Lankisch PG, Schmidt I, König H, Lehnick D, Knollmann R, Lohr M, Liebe S: Faecal elastase 1: not helpful in diagnosing chronic pancreatitis associated with mild to moderate exocrine pancreatic insufficiency. Gut 42:551–554, 1998

    Google Scholar 

  32. Carroccio A, Verghi F, Santini B, Lucidi V, Iacono G, Cavataio F, Soresi M, Ansaldi N, Castro M, Montalto G: Diagnostic accuracy of fecal elastase 1 assay in patients with pancreatic maldigestion or intestinal malabsorption: a collaborative study of the Italien Society of Pediatric Gastroenterology and Hepatology. Dig Dis Sci 46:1335–1342, 2001

    Google Scholar 

  33. Walkowiak J, Herzig KH: Fecal elastase-1 is decreased in villous atrophy regardless of the underlying disease. Eur J Clin Invest 31:425–430, 2001

    Google Scholar 

  34. DiMagno EP, Go VL, Summerskill WH: Relations between pancreatic enzyme outputs and malabsorption in severe pancreatic insufficiency. N Engl J Med 288:813–815, 1973

    Google Scholar 

  35. Nakamura T, Takebe K, Kudoh K, Ishii M, Iamura K, Kikuchi H, Kasai F, Tando Y, Yamada N, Arai Y: Steatorrhea in Japanese patients with chronic pancreatitis. J Gastroenterol 30:79–83, 1995

    Google Scholar 

  36. Doerr W: Pathogenese der akuten und chronischen Pankreatitis. Verh Dtsch Ges Inn Med 70:718–758, 1964

    Google Scholar 

  37. Olsen TS: The incidence and clinical relevance of chronic inflammation in the pancreas in autopsie material. Acta Pathol Microbiol Scand (A) 86:361–364, 1978

    Google Scholar 

  38. Aparisi QL, Sabater OL, Calvete CJ, Camps VB, Sastre BJ, Bautista RD: Early carbohydrate metabolism dysfunction in chronic pancreatitis. Relation with the exocrine pancreatic function. Med Clin (Barc) 117:561–566, 2001

    Google Scholar 

  39. Moran CE, Sosa EG, Martinez SM, Geldern P, Messina D, Russo A: Bone mineral density in patients with pancreatic insufficiency and steatorrhea. Am J Gastroenterol 92:867–871, 1997

    Google Scholar 

  40. Teichmann J, Lange U, Hardt P, Schnell-Kretschmer H, Stracke H, Bretzel RG, Kloer HU: Pancreatic elastase 1 content: an independent risk factor of the osteoporosis in elderly women. Bone 28(suppl):S194, 2001

    Google Scholar 

  41. Fassbender WJ: Knochen-, Bindegewebs-und Gelenksbeteiligung bei Diabetes mellitus. In RG Bretzel (ed): Diabetes mellitus—Prävention und Therapie diabetischer Folgeerkrankungen. Bremen, Unimed, 2000, pp 125–131

    Google Scholar 

Download references

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hardt, P.D., Hauenschild, A., Jaeger, C. et al. High Prevalence of Steatorrhea in 101 Diabetic Patients Likely to Suffer from Exocrine Pancreatic Insufficiency According to Low Fecal Elastase 1 Concentrations: A Prospective Multicenter Study. Dig Dis Sci 48, 1688–1692 (2003). https://doi.org/10.1023/A:1025422423435

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1025422423435

Navigation